Horse anti-thymocyte globulin
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Horse anti-thymocyte globulin, covering 2025-12-01 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome [Phase 2]